Siddhartha Sivaramakrishnan - McDermott Will & Emery


Siddhartha Sivaramakrishnan focuses his practice on the representation of APAC and EMEA investment bank underwriters, issuers and vendors in a wide range of US and international capital markets transactions. These include numerous equity and debt offerings under Rule 144A and Regulation S and SEC-registered offerings. Siddhartha also advises on M&A, de-SPAC and restructuring transactions.

Show More


  • Advised Innovative International Acquisition Corp., a NASDAQ-listed SPAC, in its definitive merger agreement with Zoomcar, the world’s largest emerging market focused car sharing platform. The implied enterprise value of the combined company is US$456 million
  • Advised a Baltic gaming operator on its restructuring of its outstanding senior secured notes and related consent solicitation
  • Advised Kotak, Citi, Nomura and Haitong on the US$ 872 million IPO on the Bombay Stock Exchange and Rule 144A/Regulation S global offering of Gland Pharma, a leading generic injectables manufacturer majority owned by global pharmaceutical major Shanghai Fosun Pharma*

Show More


  • Chambers Global, Leading Lawyer in Singapore and India: Capital Markets, 2022
  • Chambers Asia-Pacific, Leading Lawyer in Singapore: Capital Markets International, 2022
  • India Business Law Journal, International A-List Lawyer, 2022
  • International Financial Law Review, Leading Lawyer in Singapore: Capital Markets, 2022
  • Legal 500 Asia-Pacific, Leading Lawyer in Singapore: Capital Markets, 2021


Yale University
University of Oxford

New York
England & Wales